Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis

Br J Haematol. 2016 Jan;172(2):287-90. doi: 10.1111/bjh.13475. Epub 2015 May 5.
No abstract available

Keywords: Langerhans cell histiocytosis; cladribine; cytarabine; reduced doses; refractory/progressive risk organ multisystem; salvage therapy.

Publication types

  • Letter

MeSH terms

  • Cladribine / administration & dosage*
  • Cytarabine / administration & dosage*
  • Drug Therapy, Combination
  • Female
  • Histiocytosis, Langerhans-Cell / drug therapy*
  • Humans
  • Infant
  • Male
  • Retrospective Studies
  • Salvage Therapy / methods

Substances

  • Cytarabine
  • Cladribine